Open AccessArthritis in inflammatory bowel disease
Author(s) -
Aadil Shaukat,
Aamir Shaukat,
A. Shaukat,
Kanwal Aadil,
Hooria Aamir,
Tahir Qadeer Khan
Publication year - 2016
Publication title -
annals of king edward medical university
Language(s) - English
Resource type - Journals
eISSN - 2079-7192
pISSN - 2079-0694
DOI - 10.21649/akemu.v12i1.811
Subject(s) - medicine , inflammatory bowel disease , arthritis , ankylosing spondylitis , spondylitis , disease , sulfasalazine , gastroenterology , inflammatory arthritis , ulcerative colitis
Inflammatory bowel disease is a systemic disorder with intestinal and extra-intestinal features. Arthritis is a well recognized extra intestinal manifestation. Spondylitis, sacroiliiatis are the common involvement with IBD. NSAIDs are generally recommended in the treatment with caution due to its potential of flaring up the gastrointestinal symptoms. Sulphasalazine, methotraxate, aziothioprine and anti TNF alpha agents are licensed for treatment of arthritis in IBD. This is a Review Article